Abstract
The absolute bioavailability of flumequine after semisimultaneous intramuscular administration as a water-based suspension to veal calves was 92 ± 14%. The semisimultaneous experimental design provided a reliable determination of absorption rate and demonstrated flip-flop pharmacokinetics. No period or sequence effects were detected. Calculated elimination rate, clearance, and volume of distribution after intravenous administration were comparable to values obtained from traditional design studies. The semisimultaneous experimental design proved to be valuable for the assessment of bioavailability and pharmacokinetics of drugs in food-producing animals while preventing violation of basic clearance assumptions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
J. F. M. Nouws, C. A. M. van Ginneken, and G. Ziv. Age-dependent pharmacokinetics of oxytetracycline in ruminants. J. Vet. Pharmacol. Ther. 6:59–66 (1983).
M. Atef, S. A. Al-Samarrae, and Y. M. Abdel-Hamid. Half life and volume of distribution of trimethoprim and sulfadoxine in sheep and its relation to age and weight. Zentralbl. Veterinarmed. 26:31–36 (1979).
P. Nielsen and F. Rasmussen. Influence of age on half-life of trimethoprim and sulfadoxine in goats. Acta Pharmacol. Toxicol. 38:113–119 (1976).
P. S. Collier and S. Riegelman. Estimation of absolute bioavailability assuming steady state apparent volume of distribution remains constant. J. Pharmacokin. Biopharm. 11 (2):205–215 (1983).
R. L. Wolen. The application of stable isotopes to studies of drug bioavailability and bioequivalence. J. Clin. Pharmacol. 26:419–424 (1986).
M. O. Karlsson and U. Bredberg. Estimation of bioavailability on a single occasion after semisimultaneous drug administration. Pharm. Res. 6:817–821 (1989).
M. O. Karlsson and U. Bredberg. Bioavailability estimation by semisimultaneous drug administration: A Monte Carlo simulation study. J. Pharmacokin. Biopharm. 18 (2):103–120 (1990).
M. O. Karlsson and A. Lindberg-Freijs. Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses. J. Pharmacokin. Biopharm. 18 (4): 293–311 (1990).
G. T. Wernimont. Use of Statistics to Develop and Evaluate Analytical Methods, AOAC, Arlington, VA, 1986.
H. P. Wynand. On the assessment of bioequivalence in a two-period cross-over design. Comput. Methods Prog. Biomed. 37:151–157 (1992).
G. Ziv, S. Soback, A. Bor, and B. Kurtz. Clinical pharmacokinetics of flumequine in calves. J. Vet. Pharmacol. Ther. 9:171–182 (1986).
D. J. Mevius, H. J. Breukink, P. J. M. Guelen, T. Jansen, and B. de Greve. Pharmacokinetics, metabolism and renal clearance of flumequine in veal calves. J. Vet. Pharmacol. Ther. 13:159–169 (1990).
G. M. Dorrestein, H. van Gogh, M. N. Buitelaar, and J. F. M. Nouws. Clinical pharmacology and pharmacokinetics of flumequine after intravenous, intramuscular and oral administration in pigeons (Columba livia). J. Vet. Pharmacol. Ther. 6:281–292 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meijer, B.A., Ceyssens, K.G.F., de Jong, W.T. et al. Bioavailability of Flumequine After Semisimultaneous Administration to Veal Calves. Pharm Res 11, 117–121 (1994). https://doi.org/10.1023/A:1018962131274
Issue Date:
DOI: https://doi.org/10.1023/A:1018962131274